• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Validation of the CIBMTR scoring system in predicting early relapse of multiple myeloma after autologous hematopoietic cell transplant.

作者信息

Awada Hussein, Hajj Ali Ali, Anwer Faiz, Sauter Craig, Williams Louis, Khouri Jack

机构信息

Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.

Multiple Myeloma Program, Blood and Marrow Transplant program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.

出版信息

Bone Marrow Transplant. 2023 Sep;58(9):1057-1058. doi: 10.1038/s41409-023-02024-1. Epub 2023 Jun 23.

DOI:10.1038/s41409-023-02024-1
PMID:37353570
Abstract
摘要

相似文献

1
Validation of the CIBMTR scoring system in predicting early relapse of multiple myeloma after autologous hematopoietic cell transplant.CIBMTR评分系统在预测自体造血细胞移植后多发性骨髓瘤早期复发中的验证
Bone Marrow Transplant. 2023 Sep;58(9):1057-1058. doi: 10.1038/s41409-023-02024-1. Epub 2023 Jun 23.
2
Prognostic scoring system after transplantation in myeloma: predicting early relapse.
Br J Haematol. 2020 Nov;191(3):323-324. doi: 10.1111/bjh.16986. Epub 2020 Jul 26.
3
Late Relapse of Multiple Myeloma with Testicular Plasmacytoma after Autologous Hematopoietic Stem Cell Transplantation: A Case Report and Review of the Literature.自体造血干细胞移植后多发性骨髓瘤合并睾丸浆细胞瘤的晚期复发：一例报告并文献复习
Ann Clin Lab Sci. 2018 Jan;48(1):120-125.
4
Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk.骨髓瘤自体移植后的早期复发与生存不良相关，无论细胞遗传学风险如何。
Haematologica. 2020 Sep 1;105(9):e480-483. doi: 10.3324/haematol.2019.236588.
5
Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma.年龄不是障碍：CIBMTR 对接受自体造血细胞移植治疗多发性骨髓瘤的老年患者的分析。
Cancer. 2020 Dec 1;126(23):5077-5087. doi: 10.1002/cncr.33171. Epub 2020 Sep 23.
6
Predictive impact of circulating microRNA-193a-5p on early relapse after autologous stem cell transplantation in patients with multiple myeloma.循环 microRNA-193a-5p 对多发性骨髓瘤患者自体干细胞移植后早期复发的预测影响。
Br J Haematol. 2020 May;189(3):518-523. doi: 10.1111/bjh.16413. Epub 2020 Feb 6.
7
An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT.多发性骨髓瘤移植后早期复发预测评分：来自 EBMT 慢性恶性肿瘤工作组的一项大型队列研究。
Bone Marrow Transplant. 2023 Aug;58(8):916-923. doi: 10.1038/s41409-023-01999-1. Epub 2023 May 9.
8
Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma.修订后的国际分期系统对新诊断多发性骨髓瘤自体移植后早期复发（<24 个月）具有预测和预后价值。
Biol Blood Marrow Transplant. 2019 Apr;25(4):683-688. doi: 10.1016/j.bbmt.2018.12.141. Epub 2018 Dec 21.
9
The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.大剂量化疗在多发性骨髓瘤治疗中的作用：一场争议。
Ann Oncol. 2000;11 Suppl 1:55-8.
10
Comparison of autologous hematopoietic cell transplantation performed in tandem and in disease relapse in multiple myeloma patients.自体造血干细胞移植在多发性骨髓瘤患者疾病缓解期与复发时的疗效比较。
Neoplasma. 2018 Nov 15;65(6):952-957. doi: 10.4149/neo_2018_170511N346. Epub 2018 Jun 17.

引用本文的文献

1
Definers and drivers of functional high-risk multiple myeloma: insights from genomic, transcriptomic, and immune profiling.功能性高危多发性骨髓瘤的定义因素和驱动因素：来自基因组、转录组和免疫分析的见解
Front Oncol. 2023 Oct 2;13:1240966. doi: 10.3389/fonc.2023.1240966. eCollection 2023.

本文引用的文献

1
Multiple myeloma: 2022 update on diagnosis, risk stratification, and management.多发性骨髓瘤：2022 年诊断、风险分层和治疗的更新。
Am J Hematol. 2022 Aug;97(8):1086-1107. doi: 10.1002/ajh.26590. Epub 2022 May 23.
2
Trends in autologous stem cell transplantation for newly diagnosed multiple myeloma: Changing demographics and outcomes in European Society for Blood and Marrow Transplantation centres from 1995 to 2019.新诊断多发性骨髓瘤自体干细胞移植的趋势：1995年至2019年欧洲血液和骨髓移植学会中心的人口统计学变化及结果
Br J Haematol. 2022 Apr;197(1):82-96. doi: 10.1111/bjh.18025. Epub 2022 Feb 15.
3
Novel prognostic scoring system for autologous hematopoietic cell transplantation in multiple myeloma.
新型多发性骨髓瘤自体造血细胞移植预后评分系统。
Br J Haematol. 2020 Nov;191(3):442-452. doi: 10.1111/bjh.16987. Epub 2020 Oct 23.
4
Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk.骨髓瘤自体移植后的早期复发与生存不良相关，无论细胞遗传学风险如何。
Haematologica. 2020 Sep 1;105(9):e480-483. doi: 10.3324/haematol.2019.236588.
5
Dramatically improved survival in multiple myeloma patients in the recent decade: results from a Swedish population-based study.近十年多发性骨髓瘤患者的生存率显著提高：一项基于瑞典人群研究的结果
Haematologica. 2018 Sep;103(9):e412-e415. doi: 10.3324/haematol.2017.183475. Epub 2018 Mar 22.
6
A comparison of two antismoking interventions among pregnant women in eleven private primary care practices.
J Fam Pract. 1989 Mar;28(3):283-8.